Market Overview:
The global neglected tropical diseases drugs and vaccine market is expected to grow at a CAGR of 9.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of neglected tropical diseases, rising awareness about these diseases, and initiatives by governments and non-governmental organizations (NGOs) for their prevention and control. The malaria segment is expected to account for the largest share of the global neglected tropical diseases drugs and vaccine market in 2018. This segment is projected to grow at a CAGR of 10% during the forecast period. The Ebola segment is expected to be the fastest-growing segment, with a CAGR of 11% during the forecast period.
Product Definition:
Neglected tropical diseases (NTDs) are a group of infections that are often found in areas of the world with poor sanitation and limited access to health care. They include such diseases as cholera, leishmaniasis, onchocerciasis (river blindness), schistosomiasis (snail fever), and trachoma. NTDs can cause a wide range of symptoms, from skin rashes to blindness and death.
NTDs disproportionately affect people who live in poverty. In addition to the human toll these diseases take, they also have an economic impact by slowing development and hampering economic growth. Drug treatments for some NTDs are available, but many people do not have access to them.
Malaria:
Malaria is caused by a disease-causing parasite of the genus Plasmodium. There are over 200 different species of malaria, four of which cause most human malarial infections: P. falciparum, P. vivax, P. malariae and P. ovale (ovine).
Ebola:
Ebola is a rare infectious disease of the immune system caused by an Ebola virus. There are four types of this virus namely, Ebola-Bissu, - Bundibugyo, - Sudan and - Zaire. The name “ebola” comes from a river in the Congo River region which flows in Africa and causes this disease. It was named after a river because people who lived near that area had many deaths due to it.
Application Insights:
The drugs application segment dominated the global market with a share of over 80.0% in 2017. Drugs are widely used for the treatment, prevention and management of NTDs. The introduction of effective drugs is critical to controlling these diseases as they reduce mortality and morbidity significantly when compared to other disease control methods such as surgery or traditional medicines.
However, vaccines held the largest share in terms of revenue in 2017 owing to their ability to prevent infection by providing immunity against several infectious agents including filaria, leishmaniasis and dengue among others which results in total eradication from body tissues thereby making them useless for disease transmission. Thus, increasing focus on vaccine development is expected to drive growth during the forecast period especially during pandemic situations where there is an increased demand for vaccines due largely without a doubt towards its high efficacy resulting in total eradication from body tissues thus rendering it useless for disease transmission (2).
Regional Analysis:
The market in North America was valued at USD X billion in 2017 and is expected to grow at a significant rate over the forecast period owing to increasing prevalence of neglected tropical diseases, rising awareness about these conditions, and availability of effective treatment & vaccines. In addition, government initiatives for funding research activities on NTDs are also anticipated to propel the growth of this regional market during the forecast period. For instance, according to an article published in The Hill Magazine on August 21st 2018 titled “U.S.
Growth Factors:
- Increasing prevalence of Neglected Tropical Diseases (NTDs) across the globe: The global prevalence of NTDs is estimated to be around 1.5 billion, affecting more than one-sixth of the world’s population. This number is expected to increase in the coming years due to various factors such as unhygienic living conditions, lack of access to clean water and sanitation, and increasing population density in developing countries.
- Rising awareness about NTDs and their prevention: There has been a growing awareness about NTDs in recent years among both healthcare professionals and general public alike. This has led to an increased demand for drugs and vaccines for their prevention and treatment.
- Government initiatives for control and eradication of NTDs: A number of governments across the world have initiated programs for control or eradication of various NTDs prevalent in their countries. This is likely to result in an increased demand for drugs and vaccines for these diseases over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Neglected Tropical Diseases Drugs and Vaccine Market Research Report
By Type
Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Other
By Application
Drugs, Vaccines
By Companies
Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals, Cipla, Romark Laboratories, Toyama Chemica
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Neglected Tropical Diseases Drugs and Vaccine Market Report Segments:
The global Neglected Tropical Diseases Drugs and Vaccine market is segmented on the basis of:
Types
Malaria, Ebola, Dengue, Chagas, Leishmaniasis, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Drugs, Vaccines
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Artecef BV
- GlaxoSmithKline
- AstraZeneca
- Novartis
- Sanofi-Aventis
- Ranbaxy Labs
- Lupin
- Macleods Pharmaceuticals
- Cipla
- Romark Laboratories
- Toyama Chemica
Highlights of The Neglected Tropical Diseases Drugs and Vaccine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Malaria
- Ebola
- Dengue
- Chagas
- Leishmaniasis
- Other
- By Application:
- Drugs
- Vaccines
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neglected Tropical Diseases Drugs and Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Neglected tropical diseases (NTDs) are a group of infections that disproportionately affect the poorest and most vulnerable people in the world. They include malaria, tuberculosis, dengue fever, and cholera. NTDs are caused by bacteria or viruses that can be spread through contact with contaminated water or soil, or from an infected animal.nnThere is currently no cure for any of the NTDs, but there are many effective drugs and vaccines available to treat them. The World Health Organization (WHO) estimates that there are now more than 100 million cases of NTDs worldwide each year, causing over one million deaths annually. In addition to their health implications, NTDs also cause economic losses worth billions of dollars every year.
Some of the major players in the neglected tropical diseases drugs and vaccine market are Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals, Cipla, Romark Laboratories, Toyama Chemica.
The neglected tropical diseases drugs and vaccine market is expected to grow at a compound annual growth rate of 9.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Neglected Tropical Diseases Drugs and Vaccine Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Neglected Tropical Diseases Drugs and Vaccine Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Neglected Tropical Diseases Drugs and Vaccine Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Neglected Tropical Diseases Drugs and Vaccine Market Size & Forecast, 2018-2028
4.5.1 Neglected Tropical Diseases Drugs and Vaccine Market Size and Y-o-Y Growth
4.5.2 Neglected Tropical Diseases Drugs and Vaccine Market Absolute $ Opportunity
Chapter 5 Global Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
5.2.1 Malaria
5.2.2 Ebola
5.2.3 Dengue
5.2.4 Chagas
5.2.5 Leishmaniasis
5.2.6 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
6.2.1 Drugs
6.2.2 Vaccines
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Neglected Tropical Diseases Drugs and Vaccine Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Neglected Tropical Diseases Drugs and Vaccine Analysis and Forecast
9.1 Introduction
9.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
9.6.1 Malaria
9.6.2 Ebola
9.6.3 Dengue
9.6.4 Chagas
9.6.5 Leishmaniasis
9.6.6 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
9.10.1 Drugs
9.10.2 Vaccines
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Neglected Tropical Diseases Drugs and Vaccine Analysis and Forecast
10.1 Introduction
10.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
10.6.1 Malaria
10.6.2 Ebola
10.6.3 Dengue
10.6.4 Chagas
10.6.5 Leishmaniasis
10.6.6 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
10.10.1 Drugs
10.10.2 Vaccines
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
11.6.1 Malaria
11.6.2 Ebola
11.6.3 Dengue
11.6.4 Chagas
11.6.5 Leishmaniasis
11.6.6 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
11.10.1 Drugs
11.10.2 Vaccines
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Neglected Tropical Diseases Drugs and Vaccine Analysis and Forecast
12.1 Introduction
12.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
12.6.1 Malaria
12.6.2 Ebola
12.6.3 Dengue
12.6.4 Chagas
12.6.5 Leishmaniasis
12.6.6 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
12.10.1 Drugs
12.10.2 Vaccines
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Neglected Tropical Diseases Drugs and Vaccine Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type
13.6.1 Malaria
13.6.2 Ebola
13.6.3 Dengue
13.6.4 Chagas
13.6.5 Leishmaniasis
13.6.6 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Applications
13.10.1 Drugs
13.10.2 Vaccines
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Neglected Tropical Diseases Drugs and Vaccine Market: Competitive Dashboard
14.2 Global Neglected Tropical Diseases Drugs and Vaccine Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Artecef BV
14.3.2 GlaxoSmithKline
14.3.3 AstraZeneca
14.3.4 Novartis
14.3.5 Sanofi-Aventis
14.3.6 Ranbaxy Labs
14.3.7 Lupin
14.3.8 Macleods Pharmaceuticals
14.3.9 Cipla
14.3.10 Romark Laboratories
14.3.11 Toyama Chemica
